Xponance Inc. Has $6.37 Million Stock Holdings in The Allstate Co. (NYSE:ALL)

Xponance Inc. increased its position in The Allstate Co. (NYSE:ALL) by 9.4% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 39,871 shares of the insurance provider’s stock after purchasing an additional 3,437 shares during the quarter. Xponance Inc.’s holdings in Allstate were worth $6,366,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in ALL. Accretive Wealth Partners LLC acquired a new stake in shares of Allstate in the 4th quarter valued at about $201,000. 9258 Wealth Management LLC lifted its position in Allstate by 10.9% in the 4th quarter. 9258 Wealth Management LLC now owns 10,034 shares of the insurance provider’s stock valued at $1,405,000 after acquiring an additional 987 shares in the last quarter. Trexquant Investment LP bought a new position in Allstate in the 4th quarter valued at about $1,084,000. Cambridge Investment Research Advisors Inc. lifted its position in Allstate by 1.3% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 47,867 shares of the insurance provider’s stock valued at $6,700,000 after acquiring an additional 619 shares in the last quarter. Finally, SageView Advisory Group LLC bought a new position in Allstate in the 4th quarter valued at about $456,000. 76.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares in the company, valued at approximately $5,236,922.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CEO Thomas J. Wilson sold 90,000 shares of the company’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the transaction, the chief executive officer now directly owns 88,552 shares in the company, valued at $15,880,915.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider John E. Dugenske sold 36,367 shares of the company’s stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the transaction, the insider now owns 27,364 shares of the company’s stock, valued at $5,236,922.32. The disclosure for this sale can be found here. Insiders sold 238,305 shares of company stock worth $43,082,657 in the last three months. Corporate insiders own 1.80% of the company’s stock.

Analysts Set New Price Targets

ALL has been the topic of several recent research reports. Piper Sandler raised their price target on shares of Allstate from $188.00 to $196.00 and gave the company an “overweight” rating in a research report on Friday, August 16th. Bank of America lifted their target price on shares of Allstate from $213.00 to $226.00 and gave the stock a “buy” rating in a research report on Thursday, August 1st. Roth Mkm reissued a “buy” rating and set a $200.00 target price on shares of Allstate in a research report on Wednesday, August 14th. StockNews.com cut shares of Allstate from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 21st. Finally, The Goldman Sachs Group lifted their target price on shares of Allstate from $199.00 to $204.00 and gave the stock a “buy” rating in a research report on Thursday, August 15th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $192.76.

Allstate Stock Down 0.6 %

Allstate stock opened at $191.82 on Wednesday. The Allstate Co. has a 1-year low of $109.01 and a 1-year high of $193.97. The firm has a market capitalization of $50.62 billion, a price-to-earnings ratio of 42.34, a P/E/G ratio of 1.74 and a beta of 0.48. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.49. The firm has a 50 day simple moving average of $180.42 and a 200 day simple moving average of $170.86.

Allstate (NYSE:ALL) last released its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $1.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.33 by $1.28. Allstate had a net margin of 5.03% and a return on equity of 24.05%. The business had revenue of $15.71 billion during the quarter, compared to analyst estimates of $14.04 billion. During the same period in the previous year, the business earned ($4.42) EPS. Allstate’s revenue was up 12.4% compared to the same quarter last year. On average, analysts predict that The Allstate Co. will post 15.16 earnings per share for the current year.

Allstate Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 1st. Investors of record on Friday, August 30th will be paid a $0.92 dividend. The ex-dividend date is Friday, August 30th. This represents a $3.68 dividend on an annualized basis and a yield of 1.92%. Allstate’s dividend payout ratio is 81.24%.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.